Impact of motion management strategies on abdominal organ at risk delineation for magnetic resonance-guided radiotherapy

被引:0
|
作者
Daly, Mairead [1 ]
McDaid, Lisa [2 ]
Anandadas, Carmel [3 ]
Brocklehurst, Andrew [3 ]
Choudhury, Ananya [1 ,3 ]
McWilliam, Alan [1 ,4 ]
Radhakrishna, Ganesh [1 ,3 ]
Eccles, Cynthia L. [1 ,2 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Manchester M13 9PL, England
[2] Christie NHS Fdn Trust, Dept Radiotherapy, Manchester M20 4BX, England
[3] Christie Hosp NHS Fdn Trust, Dept Clin Oncol, Manchester M20 4BX, England
[4] Christie Hosp NHS Fdn Trust, Dept Med Phys & Engn, Manchester M20 4BX, England
关键词
Motion management; MR-guided radiotherapy; SABR; SBRT; IGRT; INTEROBSERVER VARIABILITY; VOLUME DELINEATION; MRI; SEGMENTATION; CANCER;
D O I
10.1016/j.phro.2024.100650
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: The impact of respiratory motion management strategies for abdominal radiotherapy, such as abdominal compression (AC) and breath hold (BH), on abdominal organ at risk (OAR) delineation on magnetic resonance imaging (MRI) is unknown. This feasibility study compared the inter- and intra- observer delineation variation on MRI acquired with AC, BH for three critical abdominal OAR. Materials and methods: T2-weighted (W) 3D MRI in free-breathing (FB) and with AC, and T1W 3D mDixon exhale BH were acquired. Four observers blinded to motion management strategy used, delineated stomach, liver, and duodenum on all MRI. One case per strategy was repeated over 6 weeks later to quantify intra-observer variation. Simultaneous truth and performance level estimation (STAPLE) contours for each OAR were generated, median and IQR mean distance to agreement (mDTA) and maximum Hausdorff distance (HD) between observer and STAPLE contours were calculated. Observers scored organ visibility on each MRI using a four-point Likert scale. Results: A total of 27 scans including repeats were delineated. Pooled mDTA for all OARs was 1.3 mm (0.5 mm) with AC, 1.4 mm (1.0 mm) with BH, and 1.3 mm (0.5 mm) in FB. Intra-observer mDTA was highest for all organs in FB with 10.8 mm for duodenum, 1.8 mm for liver, and 2.7 mm for stomach. The pooled mean perceptual quality score value was highest for AC across organs. Conclusions: No motion management strategy demonstrated superior similarity across OAR, emphasizing the need for personalised approaches based on individual clinical and patient factors.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] MAGELLAN: Magnetic Resonance-guided adaptive stereotactic Radiotherapy of Lung Tumors in ultracentral Location
    Regnery, S.
    Weykamp, F.
    Hoegen, P.
    Sprengel, S.
    Eichkorn, T.
    Buchele, C.
    Paul, K.
    Klueter, S.
    Pohl, M.
    Meis, J.
    Koenig, L.
    Adeberg, S.
    Koerber, S.
    Debus, J.
    Hoerner-Rieber, J.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S178 - S178
  • [42] Stereotactic radiotherapy and the potential role of magnetic resonance-guided adaptive techniques for pancreatic cancer
    Tai Ermongkonchai
    Richard Khor
    Vijayaragavan Muralidharan
    Niall Tebbutt
    Kelvin Lim
    Numan Kutaiba
    Sweet Ping Ng
    World Journal of Gastroenterology, 2022, (07) : 745 - 754
  • [43] Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
    Weykamp, Fabian
    Katsigiannopulos, Efthimios
    Piskorski, Lars
    Regnery, Sebastian
    Hoegen, Philipp
    Ristau, Jonas
    Renkamp, C. Katharina
    Liermann, Jakob
    Forster, Tobias
    Lang, Kristin
    Koenig, Laila
    Rippke, Carolin
    Buchele, Carolin
    Debus, Juergen
    Klueter, Sebastian
    Hoerner-Rieber, Juliane
    CANCERS, 2022, 14 (24)
  • [44] Clinical and economic impact of cardiac magnetic resonance-guided decision-making
    Tundidor Sanz, Maria Elena
    Barreiro Perez, Manuel
    Luengo Mondejar, Pablo
    Garcia Sanchez, Maria Jesus
    Fernandez-Vazquez, Felipe
    Sanchez Fernandez, Pedro L.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2022, 75 (07): : 610 - 611
  • [45] MAGNETIC RESONANCE-GUIDED ADAPTIVE RADIOTHERAPY REDUCES THE NORMAL TISSUE COMPLICATION PROBABILITY OF ADRENAL STEREOTACTIC ABLATIVE RADIOTHERAPY
    Chen, Hanbo
    de Koste, John van Sornsen
    Bohoudi, Omar
    Slotman, Ben
    Palacios, Miguel
    Senan, Suresh
    Lagerwaard, Frank
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S82 - S82
  • [46] Complex Abdominal Organ Motion Assessed From Magnetic Resonance Imaging
    Omari, E. A.
    Song, Y.
    Christian, J.
    Paulson, E. S.
    Erickson, B. A.
    Li, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E696 - E697
  • [47] A New Era of Image Guidance with Magnetic Resonance-guided Radiation Therapy for Abdominal and Thoracic Malignancies
    Mittauer, Kathryn
    Paliwal, Bhudatt
    Hill, Patrick
    Bayouth, John E.
    Geurts, Mark W.
    Baschnagel, Andrew M.
    Bradley, Kristin A.
    Harari, Paul M.
    Rosenberg, Stephen
    Brower, Jeffrey V.
    Wojcieszynski, Andrzej P.
    Hullett, Craig
    Bayliss, R. A.
    Labby, Zacariah E.
    Bassetti, Michael F.
    CUREUS, 2018, 10 (04):
  • [48] Dosimetric evaluation of respiratory gating on a 0.35-T magnetic resonance-guided radiotherapy linac
    Charters, John A.
    Abdulkadir, Yasin
    O'Connell, Dylan
    Yang, Yingli
    Lamb, James M.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2022, 23 (09):
  • [49] Magnetic resonance-guided radiotherapy feasibility in elderly cancer patients: proposal of the MASTER scoring system
    Boldrini, Luca
    Colloca, Giuseppe F.
    Villani, Emanuele
    Chiloiro, Giuditta
    Bellieni, Andrea
    Manfrida, Stefania
    Cellini, Francesco
    Gambacorta, Maria Antonietta
    Valentini, Vincenzo
    TUMORI JOURNAL, 2021, 107 (01): : 26 - 31
  • [50] First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany
    Klueter, Sebastian
    Katayama, Sonja
    Spindeldreier, C. Katharina
    Koerber, Stefan A.
    Major, Gerald
    Alber, Markus
    Akbaba, Sati
    Debus, Juergen
    Hoerner-Rieber, Juliane
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (08) : 691 - 698